Comparing Intermediate-dose CTX+ G-CSF Plus or Not rhTPO for PB CD34+ Cells Mobilization in MM Patients
Clinical trial NCT02572596 · UNKNOWN
Trial details
- NCT number
- NCT02572596
- Sponsor
- Wang Guorong
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2017-12-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.